Clinical Trials Logo

Filter by:
NCT ID: NCT01630733 Recruiting - Clinical trials for Non-Small Cell Lung Cancer

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

Start date: September 2012
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to compare overall survival of patients randomized to receiving custirsen in combination with docetaxel (Arm A) with patients randomized to receive docetaxel alone (Arm B).

NCT ID: NCT01628380 Recruiting - Ovarian Neoplasms Clinical Trials

Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer

CHORINE
Start date: June 2012
Phase: Phase 3
Study type: Interventional

Aim of the Study is to compare two-years disease-free survival of Cytoreductive Surgery (CRS) and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC, CDDP+Paclitaxel) vs CRS alone in Stage IIIC unresectable epithelial tubal/ovarian cancer with partial or complete response after 3 cycles of 1st line chemotherapy (CBDCA +Paclitaxel).

NCT ID: NCT01627470 Recruiting - Blood Pressure Clinical Trials

Comparison of Continuous Non-invasive Pressure Device Versus Invasive Pressure Measurement During Prehospital Emergency

Start date: August 2011
Phase: N/A
Study type: Observational

The aim of the study is to evaluate the accuracy of continuous non-invasive AP monitoring (CNAP) compared to simultaneous IBP measurement in intensive care patients undergoing a transport in the ambulance car. Since CNAP finger blood pressure is calibrated to NBP level, a systematic bias between IBP and CNAP as described by a recent FDA meta analysis [ ] is expected. The most important factor of CNAP system performance is its ability to accurately track blood pressure changes. Thus, the purpose of this investigation is to show that the bias between CNAP and IBP falls within the expected range and that blood pressure alterations are detected instantaneously. The endpoints of the study are: - The agreement of systolic, diastolic and mean CNAP and IBP readings determined on a beat-to-beat basis during: - Takeover of the patient on the intensive care unit, - Transport of the patient from the intensive care unit to the ambulance car - Transport of the patient in the ambulance car - The agreement of systolic, diastolic and mean CNAP and IBP blood pres-sure changes determined on a beat-to-beat basis during: - Takeover of the patient on the intensive care unit, - Transport of the patient from the intensive care unit to the ambulance car - Transport of the patient in the ambulance car The beat-to-beat readings of CNAP and IBP will be automatically recorded electronically on a memory card in the transport monitor. CNAP data will additionally be recorded directly on the CNAP Monitor with a memory stick. Safety will be assessed by clinical observations as well as adverse events (AE) recording.

NCT ID: NCT01624129 Recruiting - Clinical trials for Eosinophilic Esophagitis

New Serological Markers for Eosinophilic Esophagitis

Start date: January 2011
Phase: N/A
Study type: Observational

The purpose of the study is to investigate if serological parameters such as "extracellular Serum-Tryptase (ST)" and "eosinophilic cationic protein (ECP)" are useful for the diagnosis and surveillance of the eosinophilic esophagitis (EE).

NCT ID: NCT01622829 Recruiting - Physical Activity Clinical Trials

Activity on Prescription to Promote Physical Activity in Hospitalized Patients

Start date: February 2012
Phase: N/A
Study type: Interventional

This study tries to improve patient's activity by a "Prescription for Activity" led by physiotherapists in secondary health care setting. Three groups are compared in regard to their increase of physical activity.

NCT ID: NCT01619124 Recruiting - Clinical trials for Lymphoblastic Lymphoma

Osteonecroses in Pediatric Patients With ALL

OPAL
Start date: March 2012
Phase: N/A
Study type: Observational

Nowadays approximately 80% of children and adolescents with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LBL) can be cured and become long-term survivors. Avascular osteonecroses (ON) appear as serious side-effect of antileukaemic treatment. Frequently ON are first diagnosed at higher and than irreversible stages (ARCO III, IV). At these advanced stages curative treatment options are not available. Hence ON are associated with considerable morbidity concerning pain and immobility and go along with long-term impairment of quality of life. Therefore early diagnosis of ON in the follow-up of children and young adults with ALL or LBL is a pressing object. Within the prospective multicentric observational OPAL-trial patients at risk (aged 10 years or older) treated according to the clinical trials ALL-BFM(Berlin-Frankfurt-Muenster Study Group), COALL or NHL (Non Hodgkin Lymphoma)-BFM in Germany should be examined with regard to the development of ON. By using a treatment associated, risk orientated assessment and examination incidence, symptoms and the clinical course of ON are investigated. The validity of MRI screening in the early diagnosis of ON in children and young adults is analysed. Systematical investigation of patients under antileukaemic treatment is intended to contribute to risk adapted diagnostic strategies and to serve as data base for the subsequent evaluation of preventive and interventional approaches for the treatment of ON. Long-term objective is the reduction of ON-associated morbidity.

NCT ID: NCT01615172 Recruiting - Clinical trials for Neurologic Manifestations

Cannulation of the Artery Axiliaris for Extracorporeal Circulation

Start date: January 2011
Phase: N/A
Study type: Interventional

Comparision of two different cannulation techniques on the neurological outcome in cardiac surcical procedures. Study hypothesis: Cannulation of the axilaris artery can reduce neurolocical side effects.

NCT ID: NCT01614301 Recruiting - Advanced Melanoma Clinical Trials

Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

Start date: May 2012
Phase: Phase 1/Phase 2
Study type: Interventional

A prospective phase I and consecutive phase II, twoarm, randomized multi-center trial of temsirolimus in combination with pioglitazone, etoricoxib and metronomic low-dose trofosfamide versus dacarbazine (DTIC) in patients with advanced melanoma Phase I: To determine the dose of temsirolimus to be used in phase II part of the study Phase II: To determine overall survival Secondary objectives - To evalulate response rate - To evaluate time to progression (TTP) - To evalulate time to partial response (time to PR or better)(TPR) - To evaluate quality of life - To evaluate tolerability and safety

NCT ID: NCT01609712 Recruiting - Lung Function Clinical Trials

Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation

Start date: May 2012
Phase: N/A
Study type: Observational

Patients with vertebral fractures often have problems to straighten and as a consequence of impaired lung ventilation that leads to a impaired lung function. Furthermore, it comes to the sintering of the vertebra and a so-called hunchback. This also contributes to the poorer expansion of the lung. Pain is also caused by respiratory excursions of the chest which hinder the patients to use their entire lung volume. Kyphoplasty is designed to counter all these consequences of vertebral fractures by bringing stability to the fracture. In order to prove the thesis the results of lung function test (FEV1, PEF) are assessed.

NCT ID: NCT01608984 Recruiting - Myocardial Injury Clinical Trials

Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary Artery Bypass Grafting(RIPCON)

RIPCON
Start date: May 2012
Phase: Phase 1
Study type: Interventional

Purpose Remote ischemic preconditioning (RIPC) with transient upper limb ischemia reduces myocardial injury in patients undergoing On-pump coronary artery bypass (CABG) surgery with cross-clamp fibrillation or blood cardioplegia for myocardial protection. The molecular mechanisms leading to these effects are yet not fully understood. The purpose of the present study is to validate previous studies and gather further evidence for RIPC during CABG with blood cardioplegia, furthermore to determine, whether or not RIPC is still operative during Off-pump coronary artery bypass surgery (OPCAB), finally to elucidate intra-cellular mechanisms involved in myocardial protection by RIPC and their possible systemic mediators.